Updated May 2026. Learn about value-based contracting (VBC) in pharma, including the CMS Cell and Gene Therapy Access Model, IRA negotiated prices, and outcomes-based agreements for Casgevy, Lyfgenia, Beqvez, and Roctavian.
Learn about patient support hub programs in specialty pharma. This guide covers key workflows, technology, data management, and compliance for improving drug ac
Outcomes-based drug contracts and the IT/data infrastructure needed to track real-world patient outcomes. Updated April 2026 with CMS Multiple Best Prices, CGT Access Model, and IRA impacts.
Learn how health economic data like cost-effectiveness analysis is used to secure drug formulary placement and reimbursement from payers and HTA bodies.
An overview of value-based contracting (VBC) in pharmaceuticals, where drug prices are tied to patient outcomes. Covers models, challenges, case studies, CMS CGT Access Model (2025), finalized VBP rule (2026), and IRA drug price negotiations.
© 2026 IntuitionLabs. All rights reserved.
